Skip to content
★ Sign in to follow
PF

Patrik Fagerholm

Chief Financial Officer
NextCell Pharma AB
Insider activity · 24 months7 buys2 salesCumulative net flow
Total declarations
21
Company
1
▲ Purchases (11 ops.)
€57k
▼ Sales (2 ops.)
€38k

Latest filing published 16 Jun 2025 for NextCell Pharma AB, €20k.

Filing timeline

BuySale
Patrik Fagerholm

Insider track record

Disclosed buys
11
Disclosed sells
2
Signal history

Closed purchases

Market purchases
11

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Patrik Fagerholm: trading record in brief

This profile gathers the share dealings of Patrik Fagerholm in NextCell Pharma AB, where the filings describe the role as finance chief. Between 24 August 2023 and 16 June 2025, the trades on record add up to 21 filings.

The open-market side counts 11 purchases for €57k alongside 2 sales for €38k. Purchases outweigh sales by €19k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2025 alone, the filings show 5 purchases and 2 sales.

A typical purchase (the median) is worth €2,173. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.

On 16 June 2025 came the latest disclosure, an open-market purchase for €20k in NextCell Pharma AB. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Patrik Fagerholm

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    221,992 SEK0FI-SE
    218,389 shares@ SEK 1.016518.2% of flowAktieISIN SE0009723125FI:csv-6bf341b4edffc6ebf478
    Canonical exit: 11 Sept 2025 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    197,678 SEK0FI-SE
    198,891 shares@ SEK 0.993916.1% of flowAktieISIN SE0009723125FI:csv-7682af856a6899831c56
    Canonical exit: 14 Sept 2025 (T+90)
  • ▼
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    215,563 SEK21FI-SE
    217,389 shares@ SEK 0.991617.6% of flowAktieISIN SE0009723125FI:csv-9d29e540a98feb9c0e83
  • ▼
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    196,873 SEK21FI-SE
    199,891 shares@ SEK 0.984916.1% of flowAktieISIN SE0009723125FI:csv-caaf3296b5e44b6bd794
  • ●
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    0FI-SE
    298,440 shares0TeckningsoptionISIN SE0022240800FI:csv-7f2b55d333f9a487609f
  • ●
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    0FI-SE
    1,320 shares0TeckningsoptionISIN SE0022240800FI:csv-6d92c5990116a1c023f4
  • ●
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    298,440 SEK0FI-SE
    298,440 shares@ SEK 1.00BTU (betald tecknad unit)ISIN SE0022240867FI:csv-e9b12a07a2f7a060d9b4
  • ●
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    1,320 SEK19FI-SE
    1,320 shares@ SEK 1.000.0012% mcap0.4% of flowAktieISIN SE0009723125FI:A003P178-2
  • ●
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    298,440 SEK27FI-SE
    298,440 shares@ SEK 1.000.27% mcap95.4% of flowAktieISIN SE0009723125FI:A003P179-2
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    100 SEK0FI-SE
    20,000 shares@ SEK 0.0050.0% of flowTeckningsoptionISIN SE0022240800FI:A003O981-1
    Canonical exit: 25 Aug 2025 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    4,000 SEK0FI-SE
    50,000 shares@ SEK 0.081.3% of flowTeckningsoptionISIN SE0022240800FI:A003O080-1
    Canonical exit: 7 Aug 2025 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    9,000 SEK0FI-SE
    100,000 shares@ SEK 0.092.9% of flowTeckningsoptionISIN SE0022240800FI:A003N606-1
    Canonical exit: 27 Jul 2025 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    35,400 SEK20FI-SE
    15,000 shares@ SEK 2.366.5% of flowAktieISIN SE0009723125FI:csv-923620c8a6a828007fce
    Canonical exit: 18 Mar 2025 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    25,000 SEK0FI-SE
    40,000 shares@ SEK 0.6254.6% of flowTeckningsoptionISIN SE0022240800FI:csv-ff5df43d18c460e910a2
    Canonical exit: 18 Mar 2025 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    75,790 SEK0FI-SE
    71,500 shares@ SEK 1.0614.2% of flowBTU (betald tecknad unit)ISIN SE0022240867FI:csv-32ce1a04ec5a17429bf2
    Canonical exit: 12 Sept 2024 (T+90)
  • ●
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    17,956 SEK0FI-SE
    16,940 shares@ SEK 1.063.4% of flowBTU (betald tecknad unit)ISIN SE0022240867FI:csv-83f133cac64acb815cfa
  • ●
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    1,399 SEK0FI-SE
    1,320 shares@ SEK 1.060.3% of flowBTU (betald tecknad unit)ISIN SE0022240867FI:csv-25d6b5129003d63f7b23
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    30,810 SEK20FI-SE
    7,900 shares@ SEK 3.905.5% of flowAktieISIN SE0009723125FI:csv-368c77e5c3b1dad63f90
    Canonical exit: 22 Nov 2023 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    19,250 SEK19FI-SE
    5,000 shares@ SEK 3.853.4% of flowAktieISIN SE0009723125FI:csv-5280cabc86470ad7fb2f
    Canonical exit: 22 Nov 2023 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesNextCell Pharma AB
    9,875 SEK19FI-SE
    2,500 shares@ SEK 3.951.7% of flowAktieISIN SE0009723125FI:csv-054216d1710ef8b82892
    Canonical exit: 22 Nov 2023 (T+90)

20 of 20 declarations